Celemics, Inc.

Contact Us
  • PRODUCTS
    Product Navigator
    image

    Whole Exome Sequencing Panel

    The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.

    View Detail >
  • APPLICATIONS
    Application for diverse research and clinical NGS solution
    Application Navigator
  • SERVICES
    • Whole Exome Sequencing Service NEW
      image

      Whole Exome Sequencing Panel

      The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.​

      View Detail >
    • Customized NGS Panel
      image

      Customized NGS Panel

      End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.​

      View Detail >
    • Sequencing Services
      Sequencing Services
    • Bioinformatics Services
    • Biopharma Solutions
      image

      Biopharma Solutions

      Providing NGS-based diagnostics solutions for biopharma companies. Celemics can develop and deliver a flexible customization and commercialization services while maintaining the market-leading performance for our clients interested in clinical and companion diagnostics.​ ​

      View Detail >
    • Custom NGS Assay Development
      image

      Custom NGS Assay Development​

      Tailored-fit customized assay development from designing to validation run; including not only the custom panel design but also species-specific or sequencer-specific blockers, followed by reagent conditioning to optimize the individual experiment and sequencer. ​ ​

      View Detail >
    image

    Whole Exome Sequencing Panel

    The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.​

    View Detail >
  • RESOURCES
    • Technical Resources
      image

      Technical Resources​

      Find useful information, insights and tools for your Celemics’ products and services ​ ​

      View Detail >
    • Publications
      image

      Publications​

      Explore the most up-to-date publications featuring Celemics’ products and services​ ​

      View Detail >
    • Blogs
      image

      Blogs​

      Sharing interesting stories about the world of NGS and how Celemics delivers the innovative NGS solutions to the world of science. ​ ​

      View Detail >
    image

    Technical Resources

    Find useful information, insights and tools for your Celemics’ products and services

    View Detail >
  • COMPANY
    image

    About Us​

    Introducing Celemics, your trusted partner for NGS solutions​

    View Detail >

Inherited Diseases

Genetic Variants Associated with Adverse Events after Angiotensin-Converting Enzyme Inhibitor Use: Replication after GWAS-Based Discovery

Yonsei Med J Genetic Variants Associated with Adverse Events after Angiotensin-Converting Enzyme Inhibitor Use: Replication after GWAS-Based Discovery Lee CJ, Choi B, Pak H, Park JM, Lee JH, Lee SH.…

Continue ReadingGenetic Variants Associated with Adverse Events after Angiotensin-Converting Enzyme Inhibitor Use: Replication after GWAS-Based Discovery

Blended Phenotype of Pelger-Huet Anomaly with Osteochondroma and Autosomal Recessive Deafness with Enlarged Vestibular Aqueduct

Mol Syndromol Blended Phenotype of Pelger-Huet Anomaly with Osteochondroma and Autosomal Recessive Deafness with Enlarged Vestibular Aqueduct Cinleti T, Yılmaz Uzman C, Akyol Ş, Tüfekçi Ö, Erçal MD, Giray Bozkaya…

Continue ReadingBlended Phenotype of Pelger-Huet Anomaly with Osteochondroma and Autosomal Recessive Deafness with Enlarged Vestibular Aqueduct

Spinal muscular atrophy with respiratory distress type 1 (SMARD1): a rare cause of hypotonia, diaphragmatic weakness, and respiratory failure in infants

The Turkish Journal of Pediatrics Spinal muscular atrophy with respiratory distress type 1 (SMARD1): a rare cause of hypotonia, diaphragmatic weakness, and respiratory failure in infants Pekuz S, Güzin Y,…

Continue ReadingSpinal muscular atrophy with respiratory distress type 1 (SMARD1): a rare cause of hypotonia, diaphragmatic weakness, and respiratory failure in infants

Gene Panel Sequencing Identifies a Novel RYR1 p.Ser2300Pro Variant as Candidate for Malignant Hyperthermia with Multi-Minicore Myopathy

Genes Gene Panel Sequencing Identifies a Novel RYR1 p.Ser2300Pro Variant as Candidate for Malignant Hyperthermia with Multi-Minicore Myopathy Moon YJ, Park J, Kim JR, Lee SY, Lee J, Cho YG,…

Continue ReadingGene Panel Sequencing Identifies a Novel RYR1 p.Ser2300Pro Variant as Candidate for Malignant Hyperthermia with Multi-Minicore Myopathy

Genetic Aspects of Small for Gestational Age Infants Using Targeted-Exome Sequencing and Whole-Exome Sequencing: A Single Center Study

J Clin Med Genetic Aspects of Small for Gestational Age Infants Using Targeted-Exome Sequencing and Whole-Exome Sequencing: A Single Center Study Park SJ, Lee N, Jeong SH, Jeong MH, Byun…

Continue ReadingGenetic Aspects of Small for Gestational Age Infants Using Targeted-Exome Sequencing and Whole-Exome Sequencing: A Single Center Study

End of content

No more pages to load

Older Posts
Menu
Facebook-f Instagram Linkedin-in Youtube
Menu

Celemics, Inc.

Innovate NGS-based material with novel sequencing technology
​to disrupt the paradigm of medicine, biopharma, microbiome, synthetic biology, and AgBio.​
액체생검, MRD 검출 등 정밀의료 실현에 필수적인 NGS Solution을 제공하는 글로벌 유전체분석 기술플랫폼 기업
​
19-20F, BYC Highcity Bldg. A, ​
Gasandigital 1-ro 131,Geumcheon-gu, Seoul, Korea

Menu